Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

Patients need better counseling and resources for managing chemotherapy-induced hair loss.

18% of COVID-19 survivors experience PTSD, with risk factors including age, gender, smoking, and lung damage.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Permanent micropigmentation can help cancer survivors feel better about themselves by restoring eyebrows lost during chemotherapy.

Most patients on isotretinoin for acne experience mild, dose-related side effects, but the connection to depression or bowel disease is uncertain.

Effective hair loss counseling requires understanding individual experiences, clear communication, and shared decision-making.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Breast cancer patients often worry, lose weight, and cope by praying, meditating, or seeking support.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

People with androgenetic alopecia often experience high stress, but the stress doesn't affect how the disease progresses or how well different treatments work.

The woman's hair loss pattern doesn't match typical conditions like alopecia areata or female pattern hair loss.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

The author found the Dermatology Nurses’ Association’s annual meeting valuable for both learning and making friends.

Women with PCOS are more likely to experience depressive symptoms.

Hair camouflage offers various options for hair loss, helping reduce psychological impact.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.